Valuation: Conpharm AB

Market Cap 5.2Cr 53.95L 47.15L 43.51L 40.1L 75.58L 52Cr 77.26L 2.05Cr 25Cr 2.03Cr 1.98Cr 88Cr P/E 2024
23.1x
P/E 2025 28.8x
Enterprise Value 10Cr 1.07Cr 93.56L 86.33L 79.58L 1.5Cr 103.1Cr 1.53Cr 4.06Cr 50Cr 4.02Cr 3.93Cr 173.83Cr EV / Sales 2024
8.35x
EV / Sales 2025 9.69x
Free-Float
83.79%
Yield 2024
0.3%
Yield 2025 0.3%
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2013
Director TitleAgeSince
Chairman 49 01/01/2013
Director/Board Member 47 01/01/2013
Chairman 51 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%+3.31%+34.10%+27.18% 4.51TCr
-2.60%+4.79%+18.94%+7.90% 3.07TCr
-2.44%-1.60%+52.89%+144.91% 3.05TCr
-3.46%-5.90%-25.85%+64.84% 2.69TCr
-0.77%+1.72%+15.52%+67.28% 2.55TCr
-1.59%+0.05%+42.28%+113.38% 2.14TCr
-0.13%+4.00%+33.94%+8.07% 2.11TCr
0.00%-6.58%-38.26%-63.92% 2.05TCr
-1.40%+3.56%-0.22%-16.75% 1.87TCr
Average -1.50%+0.48%+14.82%+39.21% 2.67TCr
Weighted average by Cap. -1.59%+0.74%+17.76%+42.95%

Financials

2024 2025
Net sales 1.31Cr 13.57L 11.86L 10.94L 10.09L 19.01L 13Cr 19.43L 51.44L 6.4Cr 50.96L 49.84L 22Cr 1.35Cr 14.04L 12.27L 11.32L 10.44L 19.67L 14Cr 20.11L 53.23L 6.62Cr 52.73L 51.58L 23Cr
Net income 27.81L 3L 3L 2L 2L 4L 2.78Cr 4L 10.94L 1.36Cr 10.84L 10.6L 4.68Cr 27.82L 3L 3L 2L 2L 4L 2.78Cr 4L 10.94L 1.36Cr 10.84L 10.6L 4.69Cr
Net Debt 4.16Cr 43.21L 37.76L 34.84L 32.12L 60.53L 42Cr 61.88L 1.64Cr 20Cr 1.62Cr 1.59Cr 70Cr 5.12Cr 53.11L 46.41L 42.83L 39.48L 74.41L 51Cr 76.06L 2.01Cr 25Cr 1.99Cr 1.95Cr 86Cr
Logo Conpharm AB
Slottsviken Fastighetsaktiebolag (publ), formerly Conpharm AB (publ), is a Sweden-based company involved in real estate sector. The Company owns and manages residential, office and commercial properties in peri-urban locations. Slottsviken Fastighetsaktiebolag (publ) is a real estate company that acquires, manages and develops attractive properties in urban areas with a focus on the Gothenburg region. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.
Employees
-